Retrospective Case Series — Chart-Based Descriptive Study
Also known as: retrospective case series, chart review case series, historical case series, medical records case series
A retrospective case series is an observational study that systematically describes the clinical features, treatments, and outcomes of a defined group of patients by examining pre-existing medical records or administrative data. It looks backward in time — data have already been recorded before the study begins. With no control group, no randomization, and no prospective follow-up, it sits near the base of the evidence hierarchy but remains one of the most practical and frequently published study designs in clinical medicine.
Key highlights
- Rapid and low-cost because data have already been collected in routine clinical care.
- Feasible for rare conditions or uncommon procedures where prospective enrollment would take many years.
- Provides a preliminary evidence base when no prior data exist, guiding the design of larger controlled studies.
- Can capture long follow-up periods without requiring the researcher to wait years for outcomes.
- Useful for documenting complication profiles, procedural variations, and real-world clinical practice patterns.
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
Use a retrospective case series when you need to describe the natural history, clinical spectrum, or outcomes of a specific condition or intervention and only existing records are available. It is appropriate for rare diseases or rare complications where prospective enrollment is impractical, for hypothesis generation ahead of a controlled study, and for initial safety/feasibility reporting of novel procedures. Do not use it to test causal hypotheses, to estimate incidence or prevalence in a population, or when a comparison group is scientifically required — those questions demand cohort or case-control designs. Avoid this design when record completeness is poor or when outcome ascertainment is likely to be systematically biased by the retrospective mode of data capture.
Strengths & limitations
- Rapid and low-cost because data have already been collected in routine clinical care.
- Feasible for rare conditions or uncommon procedures where prospective enrollment would take many years.
- Provides a preliminary evidence base when no prior data exist, guiding the design of larger controlled studies.
- Can capture long follow-up periods without requiring the researcher to wait years for outcomes.
- Useful for documenting complication profiles, procedural variations, and real-world clinical practice patterns.
- Absence of a control group prevents any causal inference; observed outcomes cannot be attributed to a specific intervention.
- Dependent entirely on the completeness and accuracy of pre-existing records, which were created for clinical — not research — purposes.
- Susceptible to information bias and missing data: variables not routinely documented are unavailable.
- Selection of cases may be non-representative (only those who came to the clinic or survived long enough to be captured).
- Occupies the lowest tier of the evidence hierarchy for therapeutic questions; findings require confirmation in controlled studies.
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What is the difference between a retrospective case series and a retrospective cohort study?
A retrospective cohort study defines two or more groups based on past exposure status and compares outcomes between them, enabling estimation of relative risk. A retrospective case series describes one group of patients with a shared condition or procedure without any comparison group. Cohort studies can support causal inference (albeit with limitations); case series cannot.
How many cases are needed for a case series?
There is no minimum enforced by study design — even three or four cases have been published. In practice, larger series (20 or more cases) carry more descriptive value and are more credible. The number should be large enough to capture the range of presentations and outcomes relevant to the clinical question, not chosen to reach a target p-value.
Can I calculate a p-value or confidence interval in a case series?
Descriptive statistics are appropriate: frequencies, proportions, medians, ranges, and confidence intervals around proportions. Hypothesis tests comparing groups are not appropriate because there is no comparison group. Confidence intervals can quantify uncertainty around single proportions (e.g., a complication rate), but should not be misread as evidence of a treatment effect.
What reporting guideline should I follow?
The PROCESS (Preferred Reporting Of CasE Series in Surgery) checklist, published by Agha et al. in 2016 in the International Journal of Surgery, is the most widely endorsed guideline for surgical case series. More general clinical case series may also benefit from CARE (CAse REport) guidance or journal-specific instructions.
When should I upgrade from a retrospective case series to a controlled design?
As soon as the clinical question shifts from 'What happened?' to 'Does this treatment work better than another?' or 'What factors predict outcome?', a controlled design is required. Upgrade to a retrospective cohort or case-control study when a comparison group can be identified from existing records, and to a prospective design when you need complete, research-quality data collection.
Sources
- 1.Kooistra, B., Dijkman, B., Einhorn, T. A., & Bhandari, M. (2009). How to design a good case series. Journal of Bone and Joint Surgery, 91(Suppl 3), 21–26.
- 2.Mayer, D. (2010). Essential Evidence-Based Medicine (2nd ed.). Cambridge University Press. Chapter on study designs.ISBN 9780521712415
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Retrospective Case Series. ScholarGate. https://scholargate.app/epidemiology/retrospective-case-series